Helena Maria Brisby
Directeur/Membre du Conseil chez PROMIMIC AB
Profil
Helena Maria Brisby is currently a Director at Promimic AB, a Director at Dynaspine Diagnostics AB, and a Professor at the University of Gothenburg.
She was formerly a Director at Oncorena Holding AB.
She holds a doctorate degree from both the University of Linköping and the University of Gothenburg.
Postes actifs de Helena Maria Brisby
| Sociétés | Poste | Début |
|---|---|---|
| PROMIMIC AB | Directeur/Membre du Conseil | 01/01/2021 |
| Dynaspine Diagnostics AB | Directeur/Membre du Conseil | - |
| University of Gothenburg | Corporate Officer/Principal | - |
Anciens postes connus de Helena Maria Brisby
| Sociétés | Poste | Fin |
|---|---|---|
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Directeur/Membre du Conseil | - |
Formation de Helena Maria Brisby
| University of Linköping | Doctorate Degree |
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROMIMIC AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Dynaspine Diagnostics AB |
